A+ = 95.0+
A = 91.0-94.9
A- = 88.0-90.9
B+ = 85.0-87.9
B = 81.0-84.9
B- = 78.0-80.9
A = 91.0-94.9
A- = 88.0-90.9
B+ = 85.0-87.9
B = 81.0-84.9
B- = 78.0-80.9
C+ = 75.0-77.9
C = 71.0-74.9
C- = 68.0-70.9
D+ = 65.0-67.9
D = 61.0-64.9
D- = 58.0-60.9
F = <58.0
C = 71.0-74.9
C- = 68.0-70.9
D+ = 65.0-67.9
D = 61.0-64.9
D- = 58.0-60.9
F = <58.0
Based on KLAS' Decision Insights data, the market energy indicator reflects the frequency with which a vendor is seriously considered and replaced compared to what would be expected based on the number of vendors in the market and the number of purchase decisions recorded.
Market average: 76.5
Software average: 81.4
Overall performance score (100-point scale) |
Trend (2021-2022) |
Total evaluations |
Culture
|
Loyalty
|
Operations
|
Product
|
Relationship
|
Value
|
||
|
Bluesight
Kit Check Bluesight for Controlled Substances 
|
90.9 |
+1%
|
n=30
|
A-
|
A
|
A-
|
A-
|
A-
|
A
|
|
| |
|
|
|
|
||||||
|
Bluesight
Medacist RxAuditor Investigate / RxAuditor
|
63.0 |
-9%
|
n=21
|
C
|
F
|
D+
|
D
|
C-
|
C-
|
|
50.0 |
100.0 |
|||||||||
culture
A-
loyalty
A
operations
A-
product
A-
relationship
A-
value
A
culture
C
loyalty
F
operations
D+
product
D
relationship
C-
value
C-
Solutions Not Ranked
Ordered alphabetically
L
|
Overall Performance Score (100-point scale) |
Total evaluations |
Culture
|
Loyalty
|
Operations
|
Product
|
Relationship
|
Value
|
|
|
Bluesight
Protenus Diversion Analytics L |
87.5 |
n=8
|
B
|
A
|
B
|
B+
|
B
|
A
|
| |
|
|
|
|
||||
|
HelioMetrics
Drug Diversion Analytics L |
86.8 |
n=9
|
B+
|
B+
|
B
|
B
|
B+
|
A
|
| |
|
|
|
|
||||
|
Imprivata
Drug Diversion Intelligence L |
68.3 |
n=10
|
F
|
C-
|
C
|
D+
|
C
|
C+
|
| |
|
|
|
|
||||
|
Omnicell
Analytics L |
70 |
n=12
|
C
|
D
|
C
|
C
|
B
|
D-
|
L
&nbps;
Bluesight
Protenus Diversion Analytics L
Protenus Diversion Analytics L
87.5
n=8
n=8
culture
B
loyalty
A
operations
B
product
B+
relationship
B
value
A
HelioMetrics
Drug Diversion Analytics L
Drug Diversion Analytics L
86.8
n=9
n=9
culture
B+
loyalty
B+
operations
B
product
B
relationship
B+
value
A
Imprivata
Drug Diversion Intelligence L
Drug Diversion Intelligence L
68.3
n=10
n=10
culture
F
loyalty
C-
operations
C
product
D+
relationship
C
value
C+
Omnicell
Analytics L
Analytics L
70
n=12
n=12
culture
C
loyalty
D
operations
C
product
C
relationship
B
value
D-
